PARIS, Feb 8 (Reuters) - French pharmaceutical company Valneva (VLS.PA), opens new tab is open to production partnerships should its COVID-19 vaccine candidate secure approval and generate enough ...

The number of authorized product suspected adverse reactions sent to EudraVigilance jumped 93% last year because of a surge in reports related to COVID-19 vaccines. Almost half of the record 3.5 ...

Big boost to India's fight against Covid-19 as Bharat Biotech's vaccine gets approval from Central Drugs Standard Control Organisation (CDSCO). The UK approved the second 'bivalent' booster for the ...

Following an FDA marketing suspension, Valneva has decided to voluntarily withdraw its chikungunya vaccine Ixchiq in the U.S. The French company announced the decision Monday, noting that the FDA has ...

French vaccine developer Valneva is closing down a site that houses both operational and R&D work, impacting 30 employee roles. The biopharma is shuttering its location in Nantes, a spot that hosts ...